Pendal Group’s Lifestance Health LFST Stock Holding History

Pendal Group’s Portfolio LFST Stock Details LFST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-13,830	Closed	-$201K	–	599
2021 Q3	$201K	Buy	13,830 +1,482	+12%	+$28.5K	﹤0.01%	560
2021 Q2	$344K	Buy	+12,348	New	+$326K	﹤0.01%	458

Other funds holding LFST

TGA

TPG GP A Fort Worth, Texas $3.68B AUM 14.99% 1-Year Est. Return

Summit Partners Boston, Massachusetts $670M AUM 6.71% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return

RSCM

Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Pendal Group's LFST Position: Q4 2021 in Review

Pendal Group sold out of Lifestance Health (LFST) in Q4 2021, closing a stake of 13,830 shares — an estimated $201K sold.

Pendal Group first reported a position in LFST in Q2 2021 and held it in 2 quarters. The position peaked at $344K in Q2 2021. 66 funds tracked by Wall St. Rank hold LFST as of Q4 2021.

Pendal Group reported no remaining Lifestance Health position as of Q4 2021 after selling out during the quarter.
Pendal Group sold 13,830 Lifestance Health shares in Q4 2021, an estimated $201K.
Pendal Group first reported a position in Lifestance Health in Q2 2021 and held it in 2 quarters.
Pendal Group's Lifestance Health position peaked at $344K in Q2 2021.
66 funds tracked by Wall St. Rank held Lifestance Health as of Q4 2021.

Based on Pendal Group's 13F filing for Q4 2021, filed 18 Jan 2022.